Introduction
Spinal cord
injury (SCI) at T6 level and above results in paralysis of the lower trunk
muscles, and reduced ability to perform forced expiratory manoeuvres in
comparison to their SCI counterparts with spared innervation to abdominal
musculature. The resulting paralysis
leads to inefficient coughing and increases risk for pulmonary complications. Sitting posture and bed mobility are
adversely affected and, diaphragmatic splinting has been reported in the
sitting position1. It is well
recognised that numerous factors affect respiratory function of people with
tetraplegia, including age, body weight, health status, lesion level,
Various
This pilot study
aimed to determine the safety and efficacy of AMFES in the management of
respiratory function in people with chronic tetraplegia, and establish
stimulation parameters and refine protocols as a preliminary step for a
multi-centre study of the role of AMFES in the management of tetraplegia. The
study was approved by the Human Research Ethics Committee of the
Subjects and
Method
The study used a
double-blind, self-controlled study, using repeated-measures within-subjects
design to compare AMFES and sham conditions in subjects with chronic
tetraplegia in both sitting and lying positions. Subjects were screened for suitability for
the study, recording gender, age, lesion level, duration
of injury, method of bladder management, postural symmetry and other physical
and health characteristics. Eight
volunteers were screened for suitability, resulting in selection of five
healthy subjects (Table 1). Four
subjects were active participants in various sports and all were naïve to
AMFES, although four had participated in other
A commercially
available stimulator (Respond Select, EMPI) delivered a standardised
stimulation current via surface electrodes (40-1004 and 40-1006, Myles Medical,
Inc. Amherst NH) arranged in a rectangular grid (Figure 1). Forced expiratory manoeuvres (FEM) and haemodynamic parameters were tested in lying and then in a
reclined sitting position. Maximal
expiratory pressure [MEP] (tested without and with stimulation) and maximal
inspiratory pressure [MIP] were determined using a custom made manometer,
followed by the other tests. Respiratory
flow rates (FEV1, peak expiratory flow rate [PEF], peak inspiratory
flow rate [PIF]) and volume (FVC) were measured using a Vitalograph
Compact II. In each position, test
manoeuvres were performed under 4 sham and 4 AMFES conditions delivered in
random order with 2 minutes rest between each procedure. Blood pressure was monitored throughout.
Data were analysed
using the maximum values derived from a minimum of three expiratory
manoeuvres. FEV1, FVC and MEP
in each position were compared using paired t-tests. Pearson correlations were
used to assess interactions of test position with injury level and duration of
injury. Data were analysed using the
SPSS statistical software package and a probability value < 0.05 was deemed
statistically significant.
Table
1. Subjects
Characteristics
|
Gender |
Age |
Duration of
Injury |
Level of
Injury |
|
BMI kg.m-2 |
Smokers |
History of AD |
|
M |
25 |
1 |
C5 / 6 |
A |
21.3 |
N |
Y |
|
M |
28 |
4 |
C6 |
A |
24.7 |
N |
N |
|
M |
20 |
4 |
C6 /C7 |
A |
26 |
N |
N |
|
F |
23 |
3 |
C7 C8 |
A |
19 |
N |
Y |
|
M |
32 |
9 |
C6 |
B |
22.9 |
Y |
Y |

Figure
1. – Grid pattern for
the electrode placement for AMFES
Results
Table
2. Respiratory function
values for sham and AMFES conditions [mean (SD)] * p < 0.05
|
Variable |
Sham |
AMFES |
|
FVC lying
(litres) |
3.3 (0.5) |
3.5 (0.5)* |
|
FVC sitting
(litres) |
3.3 (0.4) |
3.5 (0.3)* |
|
FEV1
lying (litres) |
2.8 (0.5) |
2.9 (0.4) |
|
FEV1
sitting (litres) |
2.8 (0.5) |
3.1 (0.3) |
|
MEP lying (cm
H20) |
48 (18.7) |
53 (18.9) * |
|
MEP sitting
(cm H20) |
52 (19.6) |
51 (17.4) |
AMFES augmented
FVC in both lying and sitting positions, reaching statistical significance (p
< 0.05) (Table1). Values for FEV1,
PIF and PEF were not significantly different for the test and sham conditions
in either lying or sitting position.
AMFES significantly increased MEP in lying (p < 0.05), but not in the
sitting position (p > 0.05). For all
measures, results in sitting were not significantly different to results in
lying, when comparing stimulation and sham conditions (p > 0.1). For each individual, a gradual reduction in
measured responses was observed (p > 0.05) for the repeated tests, suggesting
either an effect from fatigue, or other factors may account for this decay in
performance.
The study showed
that AMFES is safe and well tolerated in experimental conditions in healthy
subjects with chronic tetraplegia. This
intervention significantly increased FVC in comparison to sham conditions in
both lying and sitting. One subject was
observed to have reduced respiratory performance due to trunk asymmetry, which
may be exacerbated by AMFES-induced spasticity, particularly when AMFES was
delivered in the sitting position. Small
differences in FEM between lying and sitting did not reach significance. Consistent with other reports, level of
injury was observed to influence the efficacy of FEM in this group.
FVC and FEV1
were analysed using Pearson Correlation coefficients in stimulation and sham
conditions, in both test positions. A
high degree of association was identified for these parameters irrespective of
test conditions. Correlational
analysis of FEM by level of injury (in both lying and sitting), and duration of
injury (in both lying and sitting) are shown in Table 3.
Table
3. Pearson
Correlation coefficients for FVC and FEV1 with level and duration of
injury in both test positions (p > 0.05).
|
|
FVC (R2) |
FEV1
(R2) |
|||
|
Condition |
Position |
Sham |
AMFES |
Sham |
AMFES |
|
Injury Level |
Lying |
0.9 |
0.7 |
0.4 |
0.1 |
|
|
Sitting |
0.8 |
0.6 |
0.4 |
0.3 |
|
Injury
Duration |
Lying |
-0.2 |
-0.0 |
-0.5 |
-0.6 |
|
|
Sitting |
0.4 |
0.5 |
-0.5 |
-0.6 |
Diastolic blood pressure in lying was significantly elevated in AMFES in comparison to sham conditions (p < 0.05) but only in the lying position. Whilst no evidence of autonomic dysreflexia (AD) was observed during AMFES conditions, one subject showed signs of transient bradycardia which resolved spontaneously. Apart from this one observation, AMFES was safe and well tolerated by these subjects.
Discussion
Measures of
respiratory function from this pilot study are consistent with those of other
studies after SCI. These include
variation according to level and duration of injury. All subjects were fully independent in ADL,
and most were active sports participants, so it is likely that they are less
prone to respiratory disease than less active individuals with
tetraplegia. This study showed modest
but significant increases in FVC in response to AMFES and non-significant
increases in FEV1 in sitting and lying. Other pulmonary function tests did not differ
significantly between sham and AMFES conditions. Testing of the associations between FVC and
FEV1 with level and duration of injury supported the relationships
of those measures to level of injury and duration of injury. Lack of a significant change in FEV1
may reflect the small sample size, and warrants investigation in a larger
study.
Taylor et al
(2002) showed increased blood pressure in response to AMFES, inducing AD in a
subject with post-prandial hypotension.
AMFES led to a modest but significant increase in MAP, but no change in
SBP or DBP in this study, despite a history of AD in three subjects. An effect of AMFES on blood pressure may be
different in a sample including subjects with current health problems.
Conclusions
The effect of
AMFES upon several respiratory parameters appeared greater for people with
higher level tetraplegia.
Use of AMFES may
help mitigate the degree of respiratory impairment or enhance respiratory
function, which declines with time since injury.
Further
investigation is warranted in a larger and more diverse group to confirm the
effects in non-experimental conditions.
References
[1] Sinderby C et al. The role of the
diaphragm in trunk extension in tetraplegia. Paraplegia.
1992, 30(6):389-95.
[2]
Linn WS et al. Forced vital capacity in two large outpatient populations with
chronic spinal cord injury. Spinal Cord, 2001
, 39: 263-268
[3]
Kandare F et al. Breathing by
[4]
Linder SH. Functional electrical stimulation to enhance cough in quadriplegia. Chest 1993;
103:166-169.
[5]